Profile data is unavailable for this security.
About the company
KAKEN PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in the production and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment involves in the manufacture and sale of pharmaceuticals, medical devices and agricultural drugs. The Real Estate segment is engaged in the leasing of real estate.
- Revenue in JPY (TTM)72.04bn
- Net income in JPY8.03bn
- Incorporated1948
- Employees1.13k
- LocationKaken Pharmaceutical Co Ltd20F, Bunkyo Green Court Center Office2-28-8, HonkomagomeBUNKYO-KU 113-8650JapanJPN
- Phone+81 359775001
- Fax+81 359775131
- Websitehttps://www.kaken.co.jp/
More ▼
Mergers & acquisitions
| Acquired company | 4521:TYO since announced | Transaction value |
|---|---|---|
| Eisai Co Ltd-Merislon & Myonal | 0.59% | 25.10m |
Data delayed at least 20 minutes, as of May 21 2024 07:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JCR Pharmaceuticals Co Ltd | 42.87bn | 5.51bn | 82.48bn | 879.00 | 14.48 | 1.41 | 11.08 | 1.92 | 43.91 | 43.91 | 342.28 | 450.13 | 0.4349 | 0.5891 | 3.29 | -- | 5.62 | 8.66 | 8.47 | 13.46 | 72.90 | 74.51 | 12.92 | 18.24 | 1.22 | 27.69 | 0.2921 | 29.60 | 24.83 | 13.11 | 46.00 | 8.19 | 18.54 | 21.67 |
| Eiken Chemical Co Ltd | 40.05bn | 2.63bn | 82.71bn | 754.00 | 30.43 | 1.62 | 19.36 | 2.07 | 70.52 | 70.52 | 1,080.89 | 1,328.72 | 0.6262 | 2.83 | 3.40 | -- | 4.12 | 8.01 | 5.06 | 10.14 | 41.76 | 45.92 | 6.58 | 11.50 | 2.62 | -- | 0.0862 | 35.21 | -7.44 | 2.29 | -54.08 | -5.24 | 11.66 | 11.20 |
| Zeria Pharmaceutical Co Ltd | 75.73bn | 7.73bn | 106.29bn | 1.73k | 11.41 | 1.11 | 7.93 | 1.40 | 175.39 | 175.39 | 1,717.90 | 1,806.33 | 0.5304 | 1.48 | 3.99 | -- | 5.39 | 3.89 | 8.39 | 6.28 | 73.29 | 71.93 | 10.16 | 7.57 | 0.7946 | 13.04 | 0.3667 | 35.00 | 10.74 | 4.14 | 24.78 | 17.49 | 20.77 | 5.29 |
| Kyorin Pharmaceutical Co Ltd | 119.53bn | 5.32bn | 110.80bn | 2.14k | 18.50 | 0.7533 | 12.96 | 0.927 | 92.70 | 92.70 | 2,082.82 | 2,276.51 | 0.6759 | 1.34 | 2.61 | -- | 3.01 | 3.05 | 3.90 | 3.79 | 43.01 | 47.11 | 4.45 | 4.76 | 1.45 | -- | 0.138 | 66.81 | 5.53 | 1.02 | 12.68 | -4.98 | 7.41 | -7.06 |
| Torii Pharmaceutical Co Ltd | 56.28bn | 5.29bn | 110.88bn | 583.00 | 20.47 | 0.909 | 19.30 | 1.97 | 188.05 | 188.05 | 2,002.44 | 4,235.56 | 0.4288 | 2.72 | 2.25 | 96,531,740.00 | 4.03 | 6.52 | 4.44 | 7.35 | 44.83 | 49.55 | 9.40 | 17.98 | 5.58 | -- | 0.00 | 24.17 | 11.74 | -2.67 | 4.44 | 28.76 | -20.38 | 20.11 |
| Mochida Pharmaceutical Co Ltd | 102.89bn | 4.55bn | 114.10bn | 1.53k | 24.10 | 0.8436 | 17.55 | 1.11 | 126.33 | 126.33 | 2,868.81 | 3,609.64 | 0.6478 | 1.86 | 3.28 | -- | 2.86 | 4.37 | 3.44 | 5.31 | 50.61 | 52.47 | 4.42 | 6.71 | 3.31 | -- | -- | 44.88 | -0.3641 | -1.26 | -31.61 | -11.63 | 10.91 | -1.21 |
| GNI Group Ltd | 27.75bn | 9.55bn | 117.10bn | 843.00 | 12.48 | 3.38 | 9.87 | 4.22 | 188.10 | 188.10 | 554.62 | 693.41 | 0.5569 | 2.01 | 7.89 | 32,921,710.00 | 22.45 | 7.23 | 26.73 | 8.80 | 84.78 | 85.75 | 40.32 | 14.57 | 2.74 | 30.59 | 0.1417 | 0.00 | 49.32 | 38.97 | 1,981.71 | -- | 19.69 | -- |
| Takara Bio Inc | 43.51bn | 1.48bn | 130.41bn | 1.79k | 88.11 | 1.17 | 20.28 | 3.00 | 12.29 | 12.29 | 361.29 | 926.00 | 0.3474 | 1.45 | 3.71 | -- | 1.21 | 10.06 | 1.32 | 11.38 | 61.85 | 64.39 | 3.47 | 18.84 | 7.10 | -- | 0.0086 | 27.55 | -44.33 | 3.95 | -90.76 | -16.55 | 16.18 | 19.42 |
| Nxera Pharma Co Ltd | 16.43bn | -9.07bn | 132.16bn | 350.00 | -- | 2.00 | -- | 8.04 | -107.30 | -107.30 | 194.96 | 736.60 | 0.1309 | -- | 5.77 | 46,954,280.00 | -7.23 | -0.6588 | -7.78 | -0.7036 | 74.44 | 89.83 | -55.20 | -4.46 | 4.03 | -10.91 | 0.5238 | -- | -18.00 | -- | -1,982.98 | -- | -- | -- |
| Sumitomo Pharma Co Ltd | 314.56bn | -314.97bn | 134.89bn | 6.25k | -- | 0.863 | -- | 0.4288 | -792.79 | -792.79 | 791.76 | 392.82 | 0.308 | 1.21 | 3.76 | -- | -30.84 | -5.07 | -54.58 | -7.73 | 59.76 | 69.99 | -100.12 | -12.28 | 0.2992 | -- | 0.7285 | -- | -43.38 | -7.29 | -322.71 | -- | 4.02 | -- |
| Towa Pharmaceutical Co Ltd | 227.93bn | 16.17bn | 140.64bn | 4.30k | 8.31 | 0.8619 | 5.69 | 0.617 | 328.58 | 328.58 | 4,630.88 | 3,167.26 | 0.5684 | 1.51 | 3.66 | -- | 4.03 | 4.21 | 5.03 | 5.63 | 35.70 | 39.23 | 7.10 | 7.23 | 1.46 | -- | 0.5649 | 20.79 | 9.13 | 16.74 | 634.80 | 3.72 | 28.20 | 10.86 |
| Kissei Pharmaceutical Co Ltd | 75.58bn | 11.16bn | 155.82bn | 1.80k | 12.82 | 0.6349 | 10.02 | 2.06 | 246.57 | 246.57 | 1,669.95 | 4,977.43 | 0.3135 | 1.56 | 2.94 | -- | 4.68 | 3.61 | 5.05 | 3.90 | 49.41 | 49.47 | 14.94 | 12.69 | 4.43 | -- | 0.006 | 34.69 | 11.98 | 0.8919 | 6.00 | 15.28 | 6.58 | 10.40 |
| KAKEN PHARMACEUTICAL CO., LTD. | 72.04bn | 8.03bn | 158.03bn | 1.13k | 16.17 | 0.9062 | 18.05 | 2.19 | 212.76 | 212.76 | 1,909.11 | 3,796.04 | 0.4264 | 2.05 | 3.37 | -- | 4.75 | 6.83 | 5.40 | 7.87 | 53.49 | 54.78 | 11.14 | 14.48 | 4.72 | -- | 0.0261 | 51.19 | -1.29 | -5.21 | 47.52 | -14.70 | 0.3639 | 0.00 |
Data as of May 21 2024. Currency figures normalised to Kaken Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
15.51%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Silchester International Investors LLPas of 26 Mar 2024 | 2.22m | 4.82% |
| The Vanguard Group, Inc.as of 09 May 2024 | 1.18m | 2.56% |
| Nomura Asset Management Co., Ltd.as of 30 Apr 2024 | 1.09m | 2.37% |
| Nikko Asset Management Co., Ltd.as of 10 May 2024 | 508.30k | 1.11% |
| Daiwa Asset Management Co. Ltd.as of 29 Mar 2024 | 483.40k | 1.05% |
| BlackRock Fund Advisorsas of 09 May 2024 | 394.20k | 0.86% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 387.71k | 0.84% |
| Brandes Investment Partners LPas of 16 May 2024 | 362.80k | 0.79% |
| Dimensional Fund Advisors LPas of 30 Apr 2024 | 264.23k | 0.58% |
| Mitsubishi UFJ Asset Management Co., Ltd.as of 10 May 2024 | 240.30k | 0.52% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
